Abstract
Significance Statement Induced pluripotent stem cells (iPSCs) offer a great opportunity to recapitulate both normal and pathological development of brain tissues. Recently, three research teams have developed human-PSC technology and direct somatic cell reprogramming to allow induction of human serotonin (5-HT; 5-hydroxytryptamine) neurons in vitro. While preclinical studies have repeatedly shown that 5-HT suppresses 5-HT neuronal firing activity, one group has tested the effect of 5-HT on the neuronal activity of those 5-HT-like cells and found a paradoxical excitatory action of 5-HT. Here, we argue that few cautions in translational interpretations have to be taken into account. Nonetheless, utilizing patient-derived cells for generating disease relevant cell types truly offers a new and powerful approach for investigating mechanisms playing fundamental roles in psychiatric disorders.
Footnotes
Authors report no conflict of interest.
This work was supported by “Région Auvergne-Rhône-Alpes SCUSI 2018" https://www.auvergnerhonealpes.fr/ (grant # R18119CC).
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Jump to comment: